| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,579 | 8,534 | 8,916 | 8,757 | | Cost of Revenue | 4,381 | 8,300 |
-
| 4,288 | | | Gross Profit | 4,198 | 234 | 8,916 | 4,469 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,002 | (3,084) | 4,978 | 1,055 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,773 | 3,807 | 3,712 | 3,834 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (577) | (489) | 226 | (420) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (577) | (489) | 226 | (420) | | Interest Expense | 3,506 | 3,388 | 3,371 | 3,496 | | Income Before Tax | (4,083) | (3,877) | (3,145) | (3,916) | | Income Tax Expense | (1,447) | (1,392) | (1,094) | (1,771) | | Minority Interest | 314 | 292 | 250 | 273 | | | | Net Income From Continuing Ops | (3,178) | (2,193) | (1,801) | (1,872) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,322) | (2,193) | (1,801) | (1,872) | | Preferred Stock And Other Adjustments | (60) | (60) | (60) |
-
| | | Net Income Applicable To Common Shares | ($2,382) | ($2,253) | ($1,861) | ($1,872) |
|
0.01% Nasdaq 0.00%
Income Statement
